Novavax (NVAX) Revenue (QoQ) (2010 - 2026)
Novavax (NVAX) Revenue (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Novavax | 788.01 Mn | -2.33 Mn | 108.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.18% |
| Dec 31, 2025 | 108.87% |
| Sep 30, 2025 | -59.75% |
| Jun 30, 2025 | -73.75% |
| Mar 31, 2025 | 654.89% |
| Dec 31, 2024 | 4.50% |
| Sep 30, 2024 | -79.66% |
| Jun 30, 2024 | 342.69% |
| Mar 31, 2024 | -67.79% |
| Dec 31, 2023 | 55.81% |
| Sep 30, 2023 | -55.94% |
| Jun 30, 2023 | 424.30% |
| Mar 31, 2023 | -77.35% |
| Dec 31, 2022 | -51.35% |
| Sep 30, 2022 | 295.09% |
| Jun 30, 2022 | -73.59% |
| Mar 31, 2022 | 216.82% |
| Dec 31, 2021 | 24.24% |
| Sep 30, 2021 | -39.99% |
| Jun 30, 2021 | -33.36% |